about
Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imagingChronic inorganic arsenic exposure in vitro induces a cancer cell phenotype in human peripheral lung epithelial cellsCLPTM1L is overexpressed in lung cancer and associated with apoptosisIdentification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.Alveolar type II cells possess the capability of initiating lung tumor developmentEpigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary diseaseClinical investigation into the initial diagnosis and treatment of 1,168 lung cancer patients.Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.Cigarette smoke induces the expression of Notch3, not Notch1, protein in lung adenocarcinoma.Effect of silencing SATB1 on proliferation, invasion and apoptosis of A549 human lung adenocarcinoma cellsIdentification of mutant genes with high-frequency, high-risk, and high-expression in lung adenocarcinoma.Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patientsDNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma.CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.Activated K-RAS and its effect on morphological appearance.Low-Dose Cadmium Upregulates VEGF Expression in Lung Adenocarcinoma Cells.Development of a database system and image viewer to assist in the correlation of histopathologic features and digital image analysis with clinical and molecular genetic information.Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection.[Construction of a CD147 lentiviral expression vector and establishment of its stably transfected A549 cell line].Translating research into practice: an epilogue.GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature.Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.The upregulation of TMPRSS4, partly ascribed to the downregulation of miR‑125a‑5p, promotes the growth of human lung adenocarcinoma via the NF‑κB signaling pathway.
P2860
Q26823264-24AA164B-8B67-40AC-9B11-9A7EDD0AC924Q28394865-12B0A611-CCCF-41CD-B30F-5053A15E31FBQ28484554-A7324CA3-ACE3-45F4-9FB5-7A075C829BF9Q30929193-7577CAB3-7114-443E-B18F-E6084A94DB4EQ34535276-D96FD117-3496-4F1D-BF80-5D8D87685DC9Q34629271-05A297D3-4D59-4AB5-A62E-8428E9EE0DAFQ34993648-0AB1B504-5CB6-4FFB-92B0-FF4C9D3B398AQ35025478-B847E000-6BF2-44DB-95F3-8DD5B869B20AQ35036588-9690177C-CBA1-43A9-9B5F-A6F2EB464181Q35870279-88182306-C1FB-462E-AB3D-3FC9A082FF58Q36206228-C7B883CD-E8AC-417C-8255-82761ED30A2DQ36439343-5793A46F-FA4E-49FC-814C-027772CD5023Q36477758-C0DC5A89-9823-483F-9562-5F257F58437CQ36721411-DE59521D-8DCE-4622-8C06-B24082FC00B2Q37470875-F0A9B769-2BB7-4F6D-ABD0-224B5E2E5AC0Q37701272-313DF02E-AFC4-4137-BBC0-225ECCBE8A57Q38222722-8DE882C8-28FB-4C7F-9C2B-1DE755ECDE32Q38837495-70347727-2D35-4475-B42D-93F5E1929463Q40095964-32E36796-248B-437B-A350-3986B4C8352EQ40559745-6FEDFAB0-B59A-4BBC-BAB5-2CCC3A56F485Q41401802-7994F932-FA2E-4A25-A820-80EFC7AA05E1Q42366611-1B1E1FD8-B122-4D2A-8443-8096BE643220Q43489366-5110797A-F999-4012-94D8-565DB2739599Q44224477-68645AAD-0C49-4D87-8E0A-64FC2BC6909CQ47160378-B70C780F-B6EC-4D16-BC57-E869566DFA07Q47935970-A9CF3F31-A86D-4B11-A386-3B57860C6677Q55085728-5039B32D-7E95-486E-BF90-CF4998D9B9E5
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pulmonary adenocarcinoma: a renewed entity in 2011
@ast
Pulmonary adenocarcinoma: a renewed entity in 2011
@en
Pulmonary adenocarcinoma: a renewed entity in 2011
@nl
type
label
Pulmonary adenocarcinoma: a renewed entity in 2011
@ast
Pulmonary adenocarcinoma: a renewed entity in 2011
@en
Pulmonary adenocarcinoma: a renewed entity in 2011
@nl
prefLabel
Pulmonary adenocarcinoma: a renewed entity in 2011
@ast
Pulmonary adenocarcinoma: a renewed entity in 2011
@en
Pulmonary adenocarcinoma: a renewed entity in 2011
@nl
P2860
P3181
P1433
P1476
Pulmonary adenocarcinoma: a renewed entity in 2011
@en
P2093
Humam Kadara
Mohamed Kabbout
P2860
P3181
P356
10.1111/J.1440-1843.2011.02095.X
P407
P577
2012-01-01T00:00:00Z